ETP

Eltrombopag is an oral, small non-peptide molecule which binds to the TPO receptor via its transmembrane domain and activates the intracellular pathways to increase platelet production. It is a convenient treatment for thrombocytopenia used in immune (idiopathic) thrombocytopenia (ITP), thrombocytopenia in patients with chronic hepatitis C & patients with severe aplastic.

Features